In addition SPHK1 activity and levels of S1P have been demonstrated to be involved in resistance to cytotoxic and targeted agents in a variety of cancer types, although not oesophageal or gastric adenocarcinoma drug resistance [30, 31, 34–36, 40, 42]. The gene discussed is SPHK1; the disease is cancer.